Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-31

Clinical Trial Update: Study of Botulinum Toxin and Recovery of Hand Function After Stroke [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing botulinum toxin for recovery of hand function after stroke in patients with hemiparesis has completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: NYU Langone Health | Conditions: Stroke With Hemiparesis | Phase 3 | Status: COMPLETED | Results posted: 2019-05-31